Center for Immunotherapy

Harnessing the power of the immune system to fight cancer

Learn more about The Center for Immunotherapy's mission and research in Dr. Odunsi's Message from the Executive Director.

The Roswell Park Center for Immunotherapy (CFI) conducts Phase I and Phase II cancer immunotherapy clinical trials. Our primary goal is to address the challenge of developing effective immunologic therapies for cancer.

Immunotherapy Clinical Trials

Roswell Park maintains one of the first Clinical Research Centers in the nation to focus specifically on the development of new cancer treatments through clinical research studies. Up to 50 percent of our patients are eligible for a clinical trial.

Unsure a clinical trial is right for you? See why it's a great option!

Explore the F.A.Q.


CFI Team

Our Center for Immunotherapy researchers are working to discover future cancer cures. Find out more about the cutting-edge research, vaccines and clinical trials that our team is developing in immunotherapy.

View Our Team

CFI by the numbers

  • 1 of 28 elite universities and cancer centers in North America to make up the Cancer Immunotherapy Trial Network

  • 8 immunotherapy research laboratories

  • 3 core facilities, all in one location

  • Unlimited potential for better, lifelong cures for all cancer patients